The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report

BACKGROUND: The use of complement inhibition is well established for complement mediated thrombotic microangiopathy, but its role in secondary forms of thrombotic microangiopathy is debated. We here present a case of thrombotic microangiopathy triggered by Capnocytophaga canimorsus, illustrating the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Infect Dis
Egile Nagusiak: Bjørkto, Magnus Holter, Barratt-Due, Andreas, Nordøy, Ingvild, Dörje, Christina, Galteland, Eivind, Lind, Andreas, Hilli, Abdulkarim, Aukrust, Pål, Mjøen, Geir
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2021
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7852365/
https://ncbi.nlm.nih.gov/pubmed/33526010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-021-05789-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak